Skip to main content

. 2022 Dec 8;9(34):2205912. doi: 10.1002/advs.202205912

Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T‐Cell‐Directed Therapies

Asbjørn Christophersen ^✉, Stephanie Zühlke, Eivind G Lund, Omri Snir, Shiva Dahal‐Koirala, Louise Fremgaard Risnes, Jørgen Jahnsen, Knut E A Lundin, Ludvig M Sollid ^✉

PMCID: PMC9731676 PMID: 36482157

Adv. Sci. 2021, 8, 2102778

DOI: 10.1002/advs.202102778

In the original published article, there is an error in Figure S1, Supporting Information. Please find the correct Figure S1 below.

Figure S1 — Symptom score. Median of symptoms expressed in a VAS score (maximal value 100 mm) for the categories Pain, Bloating, Flatulence, Nausea, Satisfaction with defecation and Total complaints and GSRS questionnaire for the categories Pain, Bloating, Constipation, Diarrhea and Satiety in total n = 17 celiac disease patients undergoing a 3‐day gluten challenge. The patients are listed in Table S1 and Table S4. Grey background indicates time period of gluten ingestion.

The authors apologize for any inconvenience caused.

Contributor Information

Asbjørn Christophersen, Email: asbjoc@medisin.uio.no.

Ludvig M. Sollid, Email: l.m.sollid@medisin.uio.no

ACTIONS

RESOURCES